Location
United States, North America
Cheque size
$15M - $30M
Investment Stage
Seed
Series A
Series B
Focus Areas
Digital Health
BioTech
Medical Devices
About Investor
Jayson Punwani is a Partner at Abingworth in Menlo Park, where he writes $15 M–$30 M checks into Series A–C rounds in biopharmaceuticals, medical devices and life-science tools. His most recent investment is Xilio Therapeutics, a clinical-stage oncology company. He is based in Menlo Park, California. Before joining Abingworth, he was Senior Partner at Takeda Ventures and Principal at Pappas Capital, and he began his career as a research scientist at Bristol-Myers Squibb. He holds a PhD in Biology from the University of Utah and an MBA from UNC’s Kenan-Flagler Business School.
Previous investments
Xilio Therapeutics
95M |2021
100M |2020
StrideBio
16M |2018
Similar Investors
FF
Faraz Fatemi
United States, North America
$1M - $30M
Seed
,Series A
,AM
Alex Moore
United States, North America
$3M - $30M
Seed
,SN
Scott Nolan
United States, North America
$500K - $150M
Seed
,Series A
,MH
Matt Huang
United States, North America
$1M - $100M
Seed
,Series A
,JB
Jeff Bonforte
United States, North America
$10M - $100M
Pre Seed
,Seed
,SS
Steve Schlenker
United States, North America
$1M - $22M
Seed
,Is this Your Profile?
If you have any updates, please fill out our form.